A schematic figure describing the LINC02432/hsa-miR-98–5p/HK2 axis showing that LINC02432 regulates glycolytic rate-limiting enzyme HK2 expression and PAAD progression by acting as a ceRNA against hsa-miR-98–5p (Figure 2G). The gene discussed is LINC02432; the disease is pancreatic adenocarcinoma.